Disclosing the development and focus of sequencing and omics studies in kidney neoplasm research
We obtained a profound understanding of the developing trends and hotspots of research investigating sequencing and omics studies in kidney neoplasms. Specifically, we have highlighted three hotspots: "explore molecular mechanisms of RCC pathogenesis, progression, and metastasis", "identify molecular biomarkers of RCC for diagnosis, prognosis, and therapeutics", "investigate tumor heterogeneity and tailor personalized therapeutic strategies for RCC". Hopefully, our study will serve as a valuable reference for scientific researchers and clinical practitioners.
Authors
- Yuntao Yao (ORCID: https://orcid.org/0009-0001-4057-9470)
- Xiuwu Pan (ORCID: https://orcid.org/0000-0001-5268-0886)
- Bingnan Lu (ORCID: https://orcid.org/0000-0002-9018-7475)
- Runzhi Huang (ORCID: https://orcid.org/0000-0003-2302-7305)
- Tianyue Yang (ORCID: https://orcid.org/0000-0002-4598-4248)
- Yifan Liu (ORCID: https://orcid.org/0000-0002-4873-9694)
- Haoyu Zhang (ORCID: https://orcid.org/0009-0000-5065-2937)
- Xinyue Yang (ORCID: https://orcid.org/0000-0002-3175-1363)
- J Cui (ORCID: https://orcid.org/0000-0003-2492-5887)
- Zihui Zhao (ORCID: https://orcid.org/0009-0005-9834-2379)
- Yuanan Li
- Donghao Lyu
Institutions
- Shanghai Business School (CN)
- XinHua Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1007/s12672-025-02750-6
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- Shanghai Rising-Star Program